Nifty
Sensex
:
:
10682.20
35457.16
65.50 (0.62%)
196.62 (0.56%)

Pharmaceuticals & Drugs

Rating :
54/99

BSE: 532482 | NSE: GRANULES

100.75
-1.40 (-1.37%)
16-Nov-2018 | 3:59PM
  • Day's Open
  • Day's High
  • Day's Low
  • Previous Close
  •  103.00
  •  103.80
  •  99.35
  •  102.15
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  2085225
  •  2100.86
  •  150.00
  •  71.55

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 2,600.95
  • 15.53
  • 1
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 3,463.76
  • 0.98%
  • 1.84

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 44.88%
  • 6.71%
  • 28.89%
  • FII
  • DII
  • Others
  • 3.06%
  • 3.38%
  • 13.08%

Chart

Price | P:E | P:BV | EV:EBITDA

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 19.27
  • 8.98
  • 7.47

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 23.59
  • 11.96
  • 0.18

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 39.26
  • 9.16
  • -2.26

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 15.85
  • 18.78
  • 19.61

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 2.47
  • 3.45
  • 3.38

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 8.30
  • 10.35
  • 11.13

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Sep 18
Sep 17
Var%
Jun 18
Jun 17
Var%
Mar 18
Mar 17
Var%
Dec 17
Dec 16
Var%
Net Sales
580.87
392.56
47.97%
453.24
384.74
17.80%
503.82
362.17
39.11%
410.73
359.47
14.26%
Expenses
480.34
315.65
52.17%
380.64
308.74
23.29%
460.19
284.82
61.57%
336.70
283.14
18.92%
EBITDA
100.53
76.91
30.71%
72.60
76.00
-4.47%
43.63
77.36
-43.60%
74.03
76.33
-3.01%
EBIDTM
17.31%
19.59%
16.02%
19.75%
8.66%
21.36%
18.02%
21.23%
Other Income
4.18
6.83
-38.80%
14.74
1.32
1,016.67%
9.67
1.18
719.49%
0.86
4.27
-79.86%
Interest
7.60
10.41
-26.99%
6.54
8.21
-20.34%
6.21
7.66
-18.93%
8.23
8.36
-1.56%
Depreciation
26.53
18.59
42.71%
24.53
17.60
39.38%
20.41
18.00
13.39%
19.60
18.70
4.81%
PBT
70.59
54.74
28.96%
56.27
51.51
9.24%
26.69
52.88
-49.53%
47.06
53.54
-12.10%
Tax
23.35
19.26
21.24%
19.11
17.73
7.78%
9.50
16.59
-42.74%
16.90
17.63
-4.14%
PAT
47.23
35.48
33.12%
37.16
33.78
10.01%
17.19
36.29
-52.63%
30.16
35.91
-16.01%
PATM
8.13%
9.04%
8.20%
8.78%
3.41%
10.02%
7.34%
9.99%
EPS
2.37
1.59
49.06%
2.04
1.61
26.71%
0.81
2.00
-59.50%
1.38
1.77
-22.03%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Mar 10
Mar 09
Net Sales
1,948.66
1,684.62
1,410.57
1,357.18
1,292.92
1,095.86
764.37
653.97
475.18
461.09
289.27
Net Sales Growth
30.00%
19.43%
3.93%
4.97%
17.98%
43.37%
16.88%
37.63%
3.06%
59.40%
 
Cost Of Goods Sold
1,083.52
896.32
679.63
725.03
746.95
645.25
466.92
414.36
295.55
275.07
170.17
Gross Profit
865.14
788.30
730.93
632.15
545.97
450.61
297.45
239.60
179.63
186.02
119.11
GP Margin
44.40%
46.79%
51.82%
46.58%
42.23%
41.12%
38.91%
36.64%
37.80%
40.34%
41.18%
Total Expenditure
1,657.87
1,406.20
1,111.73
1,081.29
1,084.31
937.57
679.35
574.68
418.92
399.65
255.78
Power & Fuel Cost
-
48.22
38.67
34.97
45.73
36.70
37.71
26.28
23.07
18.61
9.42
% Of Sales
-
2.86%
2.74%
2.58%
3.54%
3.35%
4.93%
4.02%
4.86%
4.04%
3.26%
Employee Cost
-
165.21
140.19
117.57
106.96
85.84
59.71
45.46
33.38
27.78
17.73
% Of Sales
-
9.81%
9.94%
8.66%
8.27%
7.83%
7.81%
6.95%
7.02%
6.02%
6.13%
Manufacturing Exp.
-
123.40
88.60
66.97
50.89
38.68
24.34
18.90
14.71
30.79
19.63
% Of Sales
-
7.33%
6.28%
4.93%
3.94%
3.53%
3.18%
2.89%
3.10%
6.68%
6.79%
General & Admin Exp.
-
80.48
67.65
60.38
59.84
44.42
26.96
21.31
16.52
18.01
12.14
% Of Sales
-
4.78%
4.80%
4.45%
4.63%
4.05%
3.53%
3.26%
3.48%
3.91%
4.20%
Selling & Distn. Exp.
-
83.08
81.37
67.75
71.70
85.04
61.70
47.62
32.32
28.47
17.11
% Of Sales
-
4.93%
5.77%
4.99%
5.55%
7.76%
8.07%
7.28%
6.80%
6.17%
5.91%
Miscellaneous Exp.
-
9.49
15.61
8.62
2.24
1.64
2.01
0.74
3.36
0.92
17.11
% Of Sales
-
0.56%
1.11%
0.64%
0.17%
0.15%
0.26%
0.11%
0.71%
0.20%
3.31%
EBITDA
290.79
278.42
298.84
275.89
208.61
158.29
85.02
79.29
56.26
61.44
33.49
EBITDA Margin
14.92%
16.53%
21.19%
20.33%
16.13%
14.44%
11.12%
12.12%
11.84%
13.32%
11.58%
Other Income
29.45
10.84
9.93
5.62
4.34
4.31
2.06
1.38
0.80
12.28
1.00
Interest
28.58
33.06
32.26
37.07
32.35
20.43
17.67
16.99
11.99
17.55
15.68
Depreciation
91.07
76.20
71.51
58.40
52.65
29.81
23.08
20.70
18.31
18.57
11.80
PBT
200.61
180.00
204.99
186.03
127.96
112.36
46.32
42.98
26.76
37.60
7.02
Tax
68.86
63.40
65.20
61.15
37.05
37.13
13.76
13.02
5.86
7.22
2.77
Tax Rate
34.33%
35.22%
31.81%
32.87%
28.95%
33.05%
29.71%
30.29%
21.90%
19.20%
39.46%
PAT
131.74
116.60
139.79
124.89
90.91
75.23
32.57
29.95
20.90
30.37
4.25
PAT before Minority Interest
131.74
116.60
139.79
124.89
90.91
75.23
32.57
29.95
20.90
30.37
4.25
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
PAT Margin
6.76%
6.92%
9.91%
9.20%
7.03%
6.86%
4.26%
4.58%
4.40%
6.59%
1.47%
PAT Growth
-6.87%
-16.59%
11.93%
37.38%
20.84%
130.98%
8.75%
43.30%
-31.18%
614.59%
 
Unadjusted EPS
6.60
5.49
7.52
5.95
4.46
3.72
16.21
14.93
10.42
15.14
2.12

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Mar 10
Mar 09
Shareholder's Funds
1,304.18
903.60
661.60
431.16
355.96
274.85
245.09
219.78
202.38
174.94
Share Capital
25.38
22.87
21.67
20.43
20.28
20.13
20.06
20.06
21.74
21.74
Total Reserves
1,273.38
878.28
611.13
410.74
335.43
254.41
225.03
199.72
180.64
153.20
Non-Current Liabilities
488.19
187.99
246.62
356.52
343.51
202.00
112.60
58.88
163.74
195.63
Secured Loans
433.13
123.90
183.66
302.59
295.86
174.85
87.30
37.08
135.85
166.05
Unsecured Loans
0.00
0.34
0.55
0.62
13.38
0.65
0.75
0.75
10.85
17.32
Long Term Provisions
7.70
7.25
5.58
4.03
3.97
2.04
1.53
1.19
0.00
0.00
Current Liabilities
844.57
787.13
654.75
415.03
292.54
205.78
213.63
157.11
49.26
34.20
Trade Payables
252.18
215.98
181.10
187.63
135.54
91.84
75.52
51.81
37.56
28.08
Other Current Liabilities
58.67
93.43
79.21
88.98
47.78
23.77
31.39
18.65
8.77
2.77
Short Term Borrowings
525.10
473.83
392.85
124.97
100.91
85.46
102.06
83.15
0.00
0.00
Short Term Provisions
8.62
3.90
1.58
13.45
8.30
4.71
4.66
3.50
2.93
3.35
Total Liabilities
2,636.94
1,878.72
1,562.97
1,202.71
992.01
682.63
571.32
435.77
415.38
404.77
Net Block
776.73
644.34
559.94
616.55
482.47
263.46
250.42
238.62
236.77
243.09
Gross Block
1,199.63
983.66
822.98
843.76
653.90
387.41
354.50
322.61
302.76
290.73
Accumulated Depreciation
422.90
339.32
263.05
227.21
171.43
123.95
104.07
83.99
65.99
47.64
Non Current Assets
1,483.71
1,050.55
744.97
699.69
611.55
388.87
310.52
256.75
239.52
245.41
Capital Work in Progress
514.52
267.43
76.56
62.03
124.56
108.80
29.30
6.85
2.45
2.02
Non Current Investment
156.56
108.23
70.11
0.19
0.19
0.19
0.19
0.30
0.30
0.29
Long Term Loans & Adv.
35.91
30.56
38.37
20.76
4.33
16.42
30.50
10.71
0.00
0.00
Other Non Current Assets
0.00
0.00
0.00
0.15
0.00
0.00
0.12
0.27
0.00
0.00
Current Assets
1,153.23
828.16
818.00
500.36
376.92
288.88
260.26
179.02
174.29
157.40
Current Investments
0.00
0.00
0.00
0.00
0.00
9.46
0.00
0.00
0.00
0.00
Inventories
279.95
269.18
253.72
224.52
174.16
136.48
109.91
75.13
68.63
59.51
Sundry Debtors
617.08
417.70
375.35
136.91
110.91
71.02
95.01
71.61
65.85
63.12
Cash & Bank
115.64
49.80
130.29
65.31
41.75
41.71
31.98
11.99
13.47
12.84
Other Current Assets
140.57
39.83
9.97
71.58
50.10
30.21
23.36
20.29
26.32
21.93
Short Term Loans & Adv.
91.78
51.66
48.68
2.05
28.76
16.93
13.18
12.28
22.70
18.30
Net Current Assets
308.65
41.03
163.25
85.33
84.38
83.09
46.63
21.91
125.03
123.21
Total Assets
2,636.94
1,878.71
1,562.97
1,202.72
992.01
682.64
571.31
435.77
415.38
404.77

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Mar 10
Mar 09
Cash From Operating Activity
-0.65
188.24
151.43
150.28
107.95
91.18
25.60
48.56
59.73
-12.28
PBT
180.00
204.99
186.03
127.96
112.36
46.32
42.98
26.76
37.60
7.02
Adjustment
107.45
95.14
92.63
85.37
50.39
41.46
37.74
33.11
24.93
24.16
Changes in Working Capital
-230.03
-52.37
-79.70
-31.34
-31.03
14.60
-43.61
-5.70
3.46
-42.83
Cash after chg. in Working capital
57.42
247.77
198.97
182.00
131.73
102.39
37.11
54.16
65.99
-11.65
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-58.07
-59.53
-47.54
-31.72
-23.78
-11.20
-11.51
-5.60
-6.26
-0.63
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-462.31
-326.09
-161.65
-145.55
-254.63
-127.79
-54.47
-25.09
-13.36
-8.83
Net Fixed Assets
-282.01
-249.86
-75.62
-231.53
-64.60
-89.18
-54.67
-23.22
-10.88
-2.27
Net Investments
-0.01
13.84
-16.48
72.98
-94.69
-17.96
-10.20
0.00
-0.93
0.00
Others
-180.29
-90.07
-69.55
13.00
-95.34
-20.65
10.40
-1.87
-1.55
-6.56
Cash from Financing Activity
528.62
55.87
85.67
18.83
146.72
46.33
48.86
-24.96
-45.73
23.10
Net Cash Inflow / Outflow
65.66
-81.98
75.44
23.56
0.04
9.72
19.99
-1.49
0.64
1.99
Opening Cash & Equivalents
42.37
124.35
54.85
41.75
41.71
31.98
11.99
13.47
12.84
10.85
Closing Cash & Equivalent
108.03
42.37
130.29
65.31
41.75
41.71
31.98
11.99
13.47
12.84

Financial Ratios

Consolidated /

Standalone
Description
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Mar 10
Mar 09
Book Value (Rs.)
51.17
39.40
29.20
20.98
17.36
13.40
12.19
10.96
9.93
8.54
ROA
5.16%
8.12%
9.03%
8.31%
8.98%
5.19%
5.95%
4.91%
7.41%
1.09%
ROE
10.60%
18.23%
23.53%
23.29%
24.20%
12.67%
12.90%
9.98%
16.40%
2.49%
ROCE
11.09%
16.57%
20.16%
18.75%
19.90%
12.95%
14.89%
11.00%
15.67%
6.75%
Fixed Asset Turnover
1.55
1.59
1.66
1.77
2.14
2.11
1.96
1.54
1.58
1.21
Receivable days
111.62
100.84
67.60
33.47
29.73
38.66
45.82
52.00
50.21
62.22
Inventory Days
59.23
66.49
63.11
54.79
50.77
57.37
50.89
54.38
49.89
69.48
Payable days
59.44
64.87
59.99
53.57
43.67
44.19
40.05
38.81
29.80
38.79
Cash Conversion Cycle
111.41
102.46
70.72
34.69
36.83
51.84
56.66
67.57
70.30
92.90
Total Debt/Equity
0.75
0.73
1.01
1.14
1.25
1.00
0.83
0.63
0.73
1.06
Interest Cover
6.44
7.36
6.02
4.96
6.50
3.62
3.53
3.23
3.14
1.45

News Update:


  • Granules India reports 49% rise in Q2 consolidated net profit
    30th Oct 2018, 10:14 AM

    Total consolidated income of the company increased by 46.49% at Rs 585.05 crore for Q2FY19

    Read More
  • Granules India - Quarterly Results
    29th Oct 2018, 18:17 PM

    Read More
  • USFDA completes inspection at Granules India’s Virginia facility
    29th Oct 2018, 09:28 AM

    This facility is involved in development and manufacturing of Finished Dosages

    Read More

Source: www.accordfintech.com. Price feed provided by www.nseindia.com and www.bseindia.com value addition by www.accordfintech.com. Intraday data delayed 15 minutes.

DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.